Clinical trial
The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study
NCT07112937 is registered in ClinicalTrials.gov with The Institute of Molecular and Translational Medicine, Czech Republic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study
- Lead sponsor
- The Institute of Molecular and Translational Medicine, Czech Republic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 2, 2023
- Completion date
- December 31, 2027
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer patients